| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17K | — |
| R&D Expense | $47K | — |
| SG&A Expense | $1.5M | — |
| Operating Income | -$1.9M | — |
| Interest Expense | $61K | — |
| Pre-tax Income | -$3.0M | — |
| Net Income | -$3.0M | -52.7% |
| EPS (Basic) | -$0.05 | — |
| EPS (Diluted) | -$0.05 | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11K | -96.5% |
| Accounts Receivable | $12K | +0.0% |
| Current Assets | $11K | -97.7% |
| Total Assets | $1.6M | -27.6% |
| Current Liabilities | $622K | +55.2% |
| Total Liabilities | $622K | +55.2% |
| Stockholders' Equity | $940K | -46.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.1M | — |
| Investing Cash Flow | -$348K | — |
| Financing Cash Flow | $2.2M | — |